Acadia Pharmaceuticals buy Needham & Company LLC
Start price
09.05.24
/
50%
€15.02
Target price
09.05.25
€27.88
Performance (%)
-9.82%
Price
29.05.24
€13.54
Summary
This prediction is currently active. With a performance of -9.82%, the BUY prediction by Needham___Company_LL is trending in the wrong direction. This prediction currently runs until 09.05.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Acadia Pharmaceuticals | -3.458% |
iShares Core DAX® | -0.552% |
iShares Nasdaq 100 | -1.415% |
iShares Nikkei 225® | -0.877% |
iShares S&P 500 | -0.415% |
Comments by Needham___Company_LL for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Needham___Company_LL for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.56
09.04.24
09.04.24
€29.40
09.04.25
09.04.25
-16.37%
29.05.24
29.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.20
12.03.24
12.03.24
€29.32
12.03.25
12.03.25
-25.60%
29.05.24
29.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€33.24
28.02.25
28.02.25
-37.31%
29.05.24
29.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€24.80
24.01.24
24.01.24
€33.86
24.01.25
24.01.25
-44.17%
29.05.24
29.05.24